unmet needs
Recently Published Documents





2022 ◽  
Vol 7 (2) ◽  
pp. 171-185
Konstantinos Papamichael ◽  
Waqqas Afif ◽  
David Drobne ◽  
Marla C Dubinsky ◽  
Marc Ferrante ◽  

Biomolecules ◽  
2022 ◽  
Vol 12 (1) ◽  
pp. 111
Aleksandra H. Opinc ◽  
Joanna S. Makowska

Idiopathic inflammatory myopathies are a group of rare connective tissue diseases with a well-documented association with malignancy. The mechanisms underlying the increased risk of neoplasms in the course of myositis are not fully understood. The Pubmed database has been thoroughly screened for articles concerning cancer-associated myositis (CAM). The article summarizes the current state of knowledge on the epidemiology and pathogenesis of CAM. Furthermore, it analyses potential risk and protective factors for developing CAM, with particular emphasis on the association with distinct serological profiles. The review summarizes recommendations proposed so far for the management of CAM and presents a novel scheme for cancer screening proposed by the authors. Moreover, promising areas requiring further research were indicated.

Critical Care ◽  
2022 ◽  
Vol 26 (1) ◽  
Samuel M. Brown ◽  
Victor D. Dinglas ◽  
Narjes Akhlaghi ◽  
Somnath Bose ◽  
Valerie Banner-Goodspeed ◽  

Abstract Introduction Survivors of acute respiratory failure (ARF) commonly experience long-lasting physical, cognitive, and/or mental health impairments. Unmet medication needs occurring immediately after hospital discharge may have an important effect on subsequent recovery. Methods and analysis In this multicenter prospective cohort study, we enrolled ARF survivors who were discharged directly home from their acute care hospitalization. The primary exposure was unmet medication needs. The primary outcome was hospital readmission or death within 3 months after discharge. We performed a propensity score analysis, using inverse probability weighting for the primary exposure, to evaluate the exposure–outcome association, with an a priori sample size of 200 ARF survivors. Results We enrolled 200 ARF survivors, of whom 107 (53%) were female and 77 (39%) were people of color. Median (IQR) age was 55 (43–66) years, APACHE II score 20 (15–26) points, and hospital length of stay 14 (9–21) days. Of the 200 participants, 195 (98%) were in the analytic cohort. One hundred fourteen (57%) patients had at least one unmet medication need; the proportion of medication needs that were unmet was 6% (0–15%). Fifty-six (29%) patients were readmitted or died by 3 months; 10 (5%) died within 3 months. Unmet needs were not associated (risk ratio 1.25; 95% CI 0.75–2.1) with hospital readmission or death, although a higher proportion of unmet needs may have been associated with increased hospital readmission (risk ratio 1.7; 95% CI 0.96–3.1) and decreased mortality (risk ratio 0.13; 95% CI 0.02–0.99). Discussion Unmet medication needs are common among survivors of acute respiratory failure shortly after discharge home. The association of unmet medication needs with 3-month readmission and mortality is complex and requires additional investigation to inform clinical trials of interventions to reduce unmet medication needs. Study registration number: NCT03738774. The study was prospectively registered before enrollment of the first patient.

2022 ◽  
pp. 002076402110689
Véra Forcheron ◽  
Elodie Sacareau ◽  
Jérôme Bourgeois ◽  
Arnaud Pouchon ◽  
Mircea Polosan ◽  

Aims: To qualitatively characterize the experience, impact and needs of informal family caregivers around the communication of a diagnosis of schizophrenia. Methods: In all, 13 informal family caregivers were recruited. All were parents. Semi-structured interviews were used to explore their experience of the diagnosis of schizophrenia, the impacts of the diagnosis and the needs related to the diagnosis around its communication. Interviews were recorded, transcribed, codes generated and mixed deductive–inductive thematic analysis undertaken. Results: Participants described receiving the diagnosis of schizophrenia for their relative as a devastating experience, although some nuanced the experience with a sense of relief of finally naming the disorder and getting access to care. Caregivers’ experience and representations prior to hearing the diagnosis played an important role in the way the ‘news’ was internalized. The communication of the diagnosis constituted a starting point for acceptance of the reality of the illness in participants. Numerous unmet needs around the communication of the diagnosis were reported by participants, including personnalized support, specific explanations about the disorder and guidance on their role as caregiver. Conclusion: A specific attention must be given to the communication of the diagnosis of schizophrenia to the informal family caregivers. Information giving must be early, comprehensive, personalized and embedded into tailored education and support programmes for caregivers to facilitate illness acceptance and adaptation.

2022 ◽  
Vol 12 ◽  
Meng Li ◽  
Qiong Luo ◽  
Yanyan Tao ◽  
Xin Sun ◽  
Chenghai Liu

Drug-induced liver injury (DILI) has become a serious public health problem. For the management of DILI, discontinuation of suspicious drug or medicine is the first step, but the treatments including drugs and supporting approaches are needed. Reference to clinical patterns and disease severity grades of DILI, the treatment drugs were considered to summarize into hepatoprotective drugs (N-acetylcysteine and Glutathione, Glycyrrhizin acid preparation, Polyene phosphatidylcholine, Bicyclol, Silymarin), anticholestatic drug (Ursodeoxycholic acid, S-adenosylmethionine, Cholestyramine), immunosuppressants (Glucocorticoids) and specific treatment agents (L-carnitine, Anticoagulants). The current article reviewed the accumulated literature with evidence-based medicine researches for DILI in clinical practice. Also the drawbacks of the clinical studies involved in the article, unmet needs and prospective development for DILI therapy were discussed.

Ali Labaf ◽  
Fariba Asghari ◽  
Shahram Samadi ◽  
Atefeh Abdollahi ◽  
Seyran Zobeiry ◽  

Background: Tracheal intubation is a life-saving action in situations such as respiratory failure. However, this therapeutic approach may produce a series of side effects and physiological stress, such as pain, insomnia, anxiety, fear, etc. Methods: The present study is a qualitative research with a content analysis method conducted for a period of two years. This study's required information has been collected using non-structured face-to-face interviews with 22 patients hospitalized in emergency and intensive care units. The data were analyzed using open coding and MAXQDA 12. Results: Findings from the interviews' were divided into two main categories of mental and physical experiences. Mental experiences are divided into 12 sub-categories and physical experiences into 7 sub-categories, each of them is also divided into further categories. Inability to speak is the most frequent complaint of patients in this study. The pain was the most common physical complaint of patients, mostly due to pain in the organs and pain due to blood sampling. Conclusion: Despite special training of medical staff in emergency and intensive care units to take care of patients and to obviate their special needs, it is observing that some patients under certain conditions such as intubation still face many unmet needs.

2022 ◽  
Richardae Araojo ◽  
Christine Lee ◽  
Christine Merenda ◽  
Anne Hammer ◽  
Michelle Tarver

UNSTRUCTURED Patient perspectives are central to the U.S. Food and Drug Administration’s benefit-risk decision-making process in the evaluation of medical products. Traditional channels of communication may not be comfortable for all patients and consumers. Social media websites have increasingly been recognized by researchers as a means to gain insights on patients’ views about treatment and diagnostic options, the healthcare system, and their experiences living with their conditions. Utilizing multiple patient perspective data sources offers the FDA the opportunity to capture diverse patient voices and experiences with chronic pain. The FDA Office of Minority Health and Health Equity (OMHHE) and the Center for Devices and Radiological Health (CDRH) worked with INSPIRE (Clinica Health, Inc.) to conduct a pilot study exploring posts from INSPIRE’s own patient platform and several social media platforms to gain insights into the key challenges and barriers faced by chronic pain patients (CPPs). The most common topics discussed among CPPs were disease burden, support and advocacy needs, and proper diagnosis. The two most frequently discussed treatments were opioids or narcotics, and devices such as transcutaneous electrical nerve stimulation (TENS) machines and spinal cord stimulators. Success in pain reduction was tempered by concerns of stigmatization regarding opioid addiction and dependency. The study illustrates how social listening data may provide valuable insights into diverse patient perspectives, preferences, and unmet needs, especially for conditions that may be perceived as stigmatizing.  

Allergy ◽  
2022 ◽  
Ioana Agache ◽  
Dario Antolin‐Amerigo ◽  
Frederic de Blay ◽  
Cristina Boccabella ◽  
Cristiano Caruso ◽  

Sign in / Sign up

Export Citation Format

Share Document